EP3056492
Meglúmínsalt og kristallaform þess af lyfi (delafloxasín)
Status:
Einkaleyfi útrunniðEP appl. date:
7.10.2005EP published:
22.9.2021EP application number:
15199355.7
EP translation filed:
9.12.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
6.10.2025Expiry date:
6.10.2025
Title:
MEGLUMINE SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG (DELAFLOXACIN)
Timeline
Today
7.10.2005EP application
22.9.2021EP Publication
9.12.2021Translation submitted
15.1.2022Registration published
6.10.2025Expires
Owner
Name:
AbbVie Inc.Address:
1 North Waukegan Road, North Chicago, IL 60064, US
Inventor
Name:
Zhang, Geoff, G.Address:
Libertyville, IL 60048, US
Name:
Bradley, Michael, F.Address:
Covington, WA 98042, US
Name:
Barnes, David, M.Address:
Lake Villa, Illinois 60046, US
Name:
Henry, RodgerAddress:
Wildwood, Illinois 60030, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
617334 PDate:
8.10.2004Country:
US
Classification
Categories:
C07D 401/14, A61K 47/12, A61P 31/04
Annual fees
Number
Paid
Expires
Payer
Number: 17
Paid: 17.12.2021
Expires: 6.10.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 14.9.2022
Expires: 6.10.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 25.9.2023
Expires: 6.10.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 23.9.2024
Expires: 6.10.2025
Payer: Árnason Faktor ehf.